Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-receptor blockade, physical activity, and metabolism.

F W Lohmann1, W A Loesment, H Kaehler

  • 1InnereAbteilung, Krankenhaus Neukölln, Berlin, FRG.

Journal of Cardiovascular Pharmacology
|January 1, 1990
PubMed
Summary

This study explores how different types of beta-blockers affect the body during physical activity and metabolism. Beta1-selective blockers, like bisoprolol, have fewer negative effects on energy metabolism and potassium balance compared to nonselective blockers. Nonselective drugs strongly inhibit glycogenolysis, increase serum potassium, and reduce high-density lipoprotein cholesterol, which is important for heart health. The findings suggest that beta1-selective blockers are safer and more metabolically neutral, making them preferable for managing conditions like hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Morning fatigue in hypertensive snorers. When should obstructive sleep apnea syndrome be excluded?].

MMW Fortschritte der Medizin·2001
Same author

Sleep-disordered breathing and hypertension.

The New England journal of medicine·2000
Same author

[Hypertension-induced organ damage].

Versicherungsmedizin·1998
Same author

Influence of sleep apnea on 24-hour blood pressure.

Chest·1997
Same author

Structured patient education for out-patients with hypertension in general practice: a model project in Germany.

Journal of human hypertension·1997
Same author

Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension.

Cardiovascular drugs and therapy·1997

Area of Science:

  • Cardiovascular pharmacology
  • Exercise physiology
  • Metabolic medicine

Background:

The relationship between beta-receptor function and physical performance has been a focus of cardiovascular and metabolic research. Prior studies have established that sympathetic activity modulates energy supply and circulation during exercise. However, the specific roles of beta1 and beta2 receptors in these processes remain less defined. Existing knowledge suggests that beta-receptor blockade can influence exercise capacity and metabolic responses. Yet, the differential effects of selective versus nonselective beta-blockers on these outcomes are not fully understood. This uncertainty has led to ongoing investigations into how receptor selectivity affects physiological adaptation. No prior work had resolved the comparative metabolic impacts of beta1-selective and nonselective blockers. The need for clarity on these mechanisms has driven recent research efforts. This paper addresses these gaps by examining receptor-specific effects in a clinical context.

Purpose Of The Study:

This study aims to clarify the physiological and metabolic effects of beta-receptor blockade during physical activity. The specific problem involves understanding how beta1 and beta2 receptors contribute to energy metabolism and cardiovascular adaptation. The motivation stems from the need to distinguish between the impacts of selective and nonselective beta-blockers. The authors propose that receptor selectivity influences exercise performance and metabolic outcomes. They suggest that beta1-selective blockers may preserve certain physiological functions better than nonselective ones. The study focuses on how these drugs affect glycogenolysis, potassium homeostasis, and lipolysis. The goal is to determine which type of blocker has fewer adverse metabolic effects. This information could guide clinical choices in hypertension management.

Keywords:
beta-blocker effectsselective receptor blockademetabolic adaptationexercise physiology

Frequently Asked Questions

Beta1-selective blockers have minimal impact on glycogenolysis, while nonselective blockers significantly inhibit it.

Nonselective beta-blockers cause a distinct increase in serum potassium and slow cellular reuptake.

Beta1-selective drugs influence potassium homeostasis to a lower extent, preserving cellular balance better.

Beta1-selective blockers do not negatively affect high-density lipoprotein cholesterol, unlike nonselective ones.

Related Experiment Videos

Main Methods:

The study compares the effects of beta1-selective and nonselective beta-blockers on various physiological parameters. Researchers used a clinical trial involving 16 hypertensive patients treated with bisoprolol. They measured changes in serum potassium levels, glycogenolysis, and lipolysis. The experimental design included monitoring metabolic responses under different blockade conditions. They assessed the impact of epinephrine release on blood pressure and heart rate. The study also evaluated high-density lipoprotein cholesterol levels as a marker of atherogenesis risk. Researchers analyzed how each drug type influenced cellular potassium homeostasis. The findings were derived from both direct measurements and observed physiological responses.

Main Results:

The strongest finding is that beta1-selective blockers have minimal impact on glycogenolysis compared to nonselective ones. Serum potassium levels increased significantly under nonselective blockers but not with beta1-selective drugs. Lipolysis was strongly inhibited under nonselective blockade but less so with selective blockers. High-density lipoprotein cholesterol levels were negatively affected by nonselective drugs but not by selective ones. Epinephrine release led to reactive pressure increases and bradycardia under nonselective blockade. Beta1-selective drugs preserved potassium reuptake in cells more effectively. The study showed that bisoprolol-treated patients had stable metabolic profiles. These results suggest that beta1-selective blockers are metabolically neutral in most cases.

Conclusions:

The authors state that beta1-selective blockers are largely metabolically neutral and should be preferred over nonselective ones. They propose that these drugs preserve glycogenolysis and potassium homeostasis better. The findings suggest that nonselective blockers have more adverse effects on lipolysis and cholesterol. The study supports the use of beta1-selective drugs in hypertension management. The authors emphasize that receptor selectivity influences metabolic outcomes. They note that nonselective blockers may increase atherogenesis risk through cholesterol changes. The results align with the hypothesis that selective blockade is safer. These conclusions are based on the observed physiological responses in treated patients.

Epinephrine release can lead to reactive pressure increases and bradycardia under nonselective beta-blockade.

The authors suggest that beta1-selective blockers are metabolically neutral and should be preferred in clinical settings.